SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Landis S, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin. 1999; 49: 1213.
  • 2
    Laramore GE, Scott CB, Al-Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys. 1992; 23: 705713.
  • 3
    Schuller DE, King GW, Smith RE, Wilson HE, James AD, Batley F. Combination therapy protocol for stage III and stage IV carcinoma of the oral cavity, oropharynx, and hypopharynx. Laryngoscope. 1980; 90: 12631272.
  • 4
    Wheeler RH. Chemotherapy of patients with recurrent head and neck cancer. In: JacobsC, editor. Carcinomas of the head and neck: evaluation and management. Boston: Kluwer Academic Publishers, 1990: 171193.
  • 5
    Schuller DE. Do otolaryngologist-head and neck surgeons and/or chemotherapy have a role in the treatment of head and neck cancer? Arch Otolaryngol Head Neck Surg. 1991; 117: 498501.
  • 6
    Schuller DE, Metch B, Stein DW, Mattox D, McCracken JD. Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group. Laryngoscope. 1988; 98: 12051211.
  • 7
    Kish J, Ensley J, Benedetti D, Schuller D, Al-Sarraf M. Postoperative adjuvant treatment of advanced head and neck cancer: Wayne State University experience and Southwest Oncology Group Feasibility Trial [abstract #923]. Am Soc Clin Oncol. 1993; 12: 285.
  • 8
    Wolf G, Vikram B, Jacobs C, et al. Adjuvant chemotherapy for advanced head and neck squamous cell carcinoma: final report of the Head and Neck Contracts Program. Cancer. 1987; 60: 301311.
  • 9
    Fu K. Combined-modality therapy for head and neck cancer. Oncology. 1997; 11: 17811796.
  • 10
    Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemo-radiotherapy vs radiotherapy in patients with locally advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099 (SWOG 8892, RTOG 8817, ECOG 2388). J Clin Oncol. 1998; 16: 13101317.
  • 11
    Al-Sarraf M, Pajak TF, Byhardt RW, Beitler JJ, Salter MM, Cooper JS. Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24. Int J Radiat Oncol Biol Phys. 1997; 27: 777782.
  • 12
    Merlano M, Benasso M, Corvo R, et al. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst. 1996; 88: 583589.
  • 13
    Adelstein DJ, Li Y, Adams GL, et al. An intergroup Phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer [abstract #1624]. Proc ASCO. 2000; 19: 411a.
  • 14
    Al-Sarraf M, LeBlanc M, Giri PG, et al. Superiority of five year survival with chemo-radiotherapy (CT-RT) vs radiotherapy in patients (Pts) with locally advanced nasopharyngeal cancer (NPC). Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) Phase III study: final report [abstract #905]. Proc ASCO. 2001; 20: 2272.
  • 15
    Haller JR, Mountain RE, Schuller DE, Nag S. Mortality and morbidity with intraoperative radiotherapy for head and neck cancer. Am J Otolaryngol. 1996; 17: 308310.
  • 16
    Nag S, Schuller D, Pak V, Grecula J, Bauer C, Young D. IORT using electron beam or HDR brachytherapy for previously unirradiated head and neck cancers. Front Radiat Ther Oncol. 1997; 31: 112116.
  • 17
    Nag S, Cano ER, Demanes DJ, Puthawala AA, Vikram B. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys. 2001; 50: 11901198.
  • 18
    Schuller DE, Grecula JC, Gahbauer RA, et al. Intensified regimen for advanced head and neck squamous cell carcinomas. Arch Otolaryngol Head Neck Surg. 1997; 123: 139144.
  • 19
    Grecula JC, Schuller DE, Rhoades CA, et al. Intensification regimen 2 for advanced head and neck squamous cell carcinomas. Arch Otolaryngol Head Neck Surg. 1999; 125: 13131318.
  • 20
    Grecula JC, Smith RE, Rhoades CA, et al. Phase II trial: induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of the head and neck. Cancer. 2000; 89: 25872596.
  • 21
    Grecula JC, Schuller DE, Smith R, et al. Long-term follow-up on an intensified treatment regimen for advanced resectable head and neck squamous cell carcinomas. Cancer Invest. 2001; 19: 127136.
  • 22
    Johnstone PA, DeLuca AM, Bacher JD, et al. Clinical toxicity of peripheral nerve to intraoperative radiotherapy in a canine model. Int J Radiat Oncol Biol Phys. 1995; 32: 10311034.
  • 23
    Rubin P. The Franz Buschke lecture: late effects of chemotherapy and radiation therapy: a new hypothesis. Int J Radiat Oncol Biol Phys. 1984; 10: 534.
  • 24
    Jeremic B, Shibamoto Y, Milicic B, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol. 2000; 18: 14581464.
  • 25
    Smid L, Lesnicar H, Zakotnik B, et al. Radiotherapy, combined with simultaneous chemotherapy with mitomycin c and bleomycin for inoperable head and neck cancer – preliminary report. Int J Radiat Oncol Biol Phys. 1995; 32: 769775.
  • 26
    Wendt TG, Grabenbauer GG, Rödel CM, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol. 1998; 16: 13181324.
  • 27
    Kies MS, Haraf DJ, Rosen F, et al. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol. 2001; 19: 19611969.
  • 28
    Adelstein DJ, Lavertu P, Saxton JP, et al. Mature results of a Phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with Stage III and IV squamous cell carcinoma of the head and neck. Cancer. 2000; 88: 876883.
  • 29
    Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998; 338: 17981804.
  • 30
    Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999; 91: 20812086.
  • 31
    Bernier J, Domenge C, Eschwege F, et. al. Chemo-radiotherapy, as compared to radiotherapy alone, significantly increases disease-free and overall survival in head and neck cancer patients after surgery: results of EORTC Phase III trial 22931. Int J Radiat Oncol Biol Phys. 2001; 51: 1.
  • 32
    Schuller D, Metch B, Stein DW, Mattox D, McCracken JD. Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group. Laryngoscope. 1988; 98: 12051211.
  • 33
    Dedo DD, Alonso WA, Ogura JH. Incidence, predisposing factors, and outcome of pharyngocutaneous fistulas complicating head and neck cancer surgery. Ann Otol Rhinol Laryngol. 1975; 84: 833840.